233 related articles for article (PubMed ID: 24262448)
1. HIV neuropathy in pre-HAART patients and it's correlation with risk factors in Central India.
Dubey TN; Raghuvanshi SS; Sharma H; Saxena R
Neurol India; 2013; 61(5):478-80. PubMed ID: 24262448
[TBL] [Abstract][Full Text] [Related]
2. HIV-associated sensory neuropathy in HIV-1 infected patients at the Douala General Hospital in Cameroon: a cross-sectional study.
Luma HN; Tchaleu BC; Doualla MS; Temfack E; Sopouassi VN; Mapoure YN; Djientcheu VD
AIDS Res Ther; 2012 Nov; 9(1):35. PubMed ID: 23181417
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of and risk factors for HIV-associated neuropathy in Melbourne, Australia 1993-2006.
Smyth K; Affandi JS; McArthur JC; Bowtell-Harris C; Mijch AM; Watson K; Costello K; Woolley IJ; Price P; Wesselingh SL; Cherry CL
HIV Med; 2007 Sep; 8(6):367-73. PubMed ID: 17661844
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of highly active antiretroviral therapy in Indian human immunodeficiency virus positive patients.
Rajesh R; Vidyasagar S; Varma DM; Naik A; Hegde BM; Guddattu V; Kamath A
Int J Risk Saf Med; 2013 Jan; 25(1):53-65. PubMed ID: 23442298
[TBL] [Abstract][Full Text] [Related]
5. The impact of integrating food supplementation, nutritional education and HAART (Highly Active Antiretroviral Therapy) on the nutritional status of patients living with HIV/AIDS in Mozambique: results from the DREAM Programme.
Scarcella P; Buonomo E; Zimba I; Doro Altan AM; Germano P; Palombi L; Marazzi MC
Ig Sanita Pubbl; 2011; 67(1):41-52. PubMed ID: 21468153
[TBL] [Abstract][Full Text] [Related]
6. HIV peripheral neuropathy.
Gabbai AA; Castelo A; Oliveira AS
Handb Clin Neurol; 2013; 115():515-29. PubMed ID: 23931799
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and factors associated with peripheral neuropathy among HIV infected patients in Gondar, Ethiopia: A cross-sectional study.
Adem KS; Janakiraman B; Gebremeskel BF; Chala MB; Gelaw AY; Alemu K
PLoS One; 2019; 14(1):e0211354. PubMed ID: 30695060
[TBL] [Abstract][Full Text] [Related]
8. Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study.
Ellis RJ; Rosario D; Clifford DB; McArthur JC; Simpson D; Alexander T; Gelman BB; Vaida F; Collier A; Marra CM; Ances B; Atkinson JH; Dworkin RH; Morgello S; Grant I;
Arch Neurol; 2010 May; 67(5):552-8. PubMed ID: 20457954
[TBL] [Abstract][Full Text] [Related]
9. Peripheral neuropathy in patients with human immunodeficiency viral infection at a tertiary hospital in Ghana.
Puplampu P; Ganu V; Kenu E; Kudzi W; Adjei P; Grize L; Käser M
J Neurovirol; 2019 Aug; 25(4):464-474. PubMed ID: 31028691
[TBL] [Abstract][Full Text] [Related]
10. HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV Brain Bank.
Morgello S; Estanislao L; Simpson D; Geraci A; DiRocco A; Gerits P; Ryan E; Yakoushina T; Khan S; Mahboob R; Naseer M; Dorfman D; Sharp V;
Arch Neurol; 2004 Apr; 61(4):546-51. PubMed ID: 15096404
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a clinical screening tool for HIV-associated sensory neuropathies.
Cherry CL; Wesselingh SL; Lal L; McArthur JC
Neurology; 2005 Dec; 65(11):1778-81. PubMed ID: 16344522
[TBL] [Abstract][Full Text] [Related]
12. HIV neuropathy natural history cohort study: assessment measures and risk factors.
Simpson DM; Kitch D; Evans SR; McArthur JC; Asmuth DM; Cohen B; Goodkin K; Gerschenson M; So Y; Marra CM; Diaz-Arrastia R; Shriver S; Millar L; Clifford DB;
Neurology; 2006 Jun; 66(11):1679-87. PubMed ID: 16769940
[TBL] [Abstract][Full Text] [Related]
13. Frequency and risk factors for distal sensory polyneuropathy in HIV infection in a developing country.
Ekenze OS; Nwosu CM; Ogunniyi A
Int J STD AIDS; 2014 Mar; 25(3):178-83. PubMed ID: 23970649
[TBL] [Abstract][Full Text] [Related]
14. Sensory neuropathy in human immunodeficiency virus/acquired immunodeficiency syndrome patients: protease inhibitor-mediated neurotoxicity.
Pettersen JA; Jones G; Worthington C; Krentz HB; Keppler OT; Hoke A; Gill MJ; Power C
Ann Neurol; 2006 May; 59(5):816-24. PubMed ID: 16634006
[TBL] [Abstract][Full Text] [Related]
15. Weight and body shape changes in a treatment-naive population after 6 months of nevirapine-based generic highly active antiretroviral therapy in South India.
Saghayam S; Kumarasamy N; Cecelia AJ; Solomon S; Mayer K; Wanke C
Clin Infect Dis; 2007 Jan; 44(2):295-300. PubMed ID: 17173234
[TBL] [Abstract][Full Text] [Related]
16. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
Wong KH; Chan KC; Lee SS
Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of anemia and correlation with biomarkers and specific antiretroviral regimens in 9690 human-immunodeficiency-virus-infected patients: findings of the Anemia Prevalence Study.
Mildvan D; Creagh T; Leitz G;
Curr Med Res Opin; 2007 Feb; 23(2):343-55. PubMed ID: 17288689
[TBL] [Abstract][Full Text] [Related]
18. The frequency and outcome of neuropathies among HIV/AIDS adults treated at a tertiary hospital in Kaduna State, Nigeria.
Obiako OR; Ogoina D; Abubakar SA; Muktar HM; Sheikh TL; Tabi-Ajayi E; Kehinde JA; Iwuozo EU; Musa BO
Niger Postgrad Med J; 2014 Dec; 21(4):319-26. PubMed ID: 25633451
[TBL] [Abstract][Full Text] [Related]
19. Severe peripheral neuropathy following HAART initiation in an HIV-infected patient with leprosy.
Pavie J; De Castro N; Molina JM; Flageul B
J Int Assoc Physicians AIDS Care (Chic); 2010; 9(4):232-5. PubMed ID: 20798403
[TBL] [Abstract][Full Text] [Related]
20. Age and height predict neuropathy risk in patients with HIV prescribed stavudine.
Cherry CL; Affandi JS; Imran D; Yunihastuti E; Smyth K; Vanar S; Kamarulzaman A; Price P
Neurology; 2009 Jul; 73(4):315-20. PubMed ID: 19636052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
